BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Beckman Laser Institute - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bli.uci.edu
X-WR-CALDESC:Events for Beckman Laser Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240502T130000
DTEND;TZID=UTC:20240502T130000
DTSTAMP:20260428T215809
CREATED:20250325T194010Z
LAST-MODIFIED:20250325T194010Z
UID:31202-1714654800-1714654800@bli.uci.edu
SUMMARY:Lei S. Li\, Ph.D.
DESCRIPTION:Advancing Photoacoustic Tomography: From benchtop wholebody imagers to wearable devices \nAbstract \nThis talk will cover the recent development of photoacoustic imaging technology\, including a benchtop imager\, termed single-impulse panoramic photoacoustic computed tomography (SIP-PACT)\, and its preclinical applications. SIP-PACT has also been scaled up for breast cancer diagnosis with improved sensitivity and specificity. In addition\, to shape the benchtop PACT systems toward portable and wearable devices with low cost without compromising the imaging performance\, we recently have developed photoacoustic topography through an ergodic relay\, a high-throughput imaging system with significantly reduced system size\, complexity\, and cost\, enabling wearable applications. As a rapidly evolving imaging technique\, photoacoustic imaging promises preclinical applications and clinical translation. \n  \nBiography \nDr. Lei Li is an assistant professor of Electrical and Computer Engineering and Bioengineering at Rice University. He obtained his Ph.D. from the Department of Electrical Engineering at California Institute of Technology in 2019. He received his MS at Washington University in St. Louis in 2016. His research focuses on developing next-generation medical imaging technology for understanding the brain better\, diagnosing early-stage cancer\, and wearable monitoring of human vital signs. He was selected as a TED fellow in 2021 and a rising star in Engineering in Health by Columbia University and Johns Hopkins University (2021). He received the Charles and Ellen Wilts Prize from Caltech in 2020 and was selected as one of the Innovators Under 35 by MIT Technology Review in 2019. He is also a two-time winner of the Seno Medical Best Paper Award granted by SPIE (2017 and 2020\, San Francisco). \n  \nREGISTER HERE
URL:https://bli.uci.edu/event/lei_s_-li_phd/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2024 Hybrid Seminar Series,LAMMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2025/03/leili.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240208T120000
DTEND;TZID=America/Los_Angeles:20240208T130000
DTSTAMP:20260428T215809
CREATED:20250325T213048Z
LAST-MODIFIED:20250325T213048Z
UID:32970-1707393600-1707397200@bli.uci.edu
SUMMARY:Inga Saknite\, Ph.D.
DESCRIPTION:Smartphone-based total body photography of patients with mpox in remote areas of the Democratic Republic of the Congo\nAbstract  \nMpox (associated with clade I monkeypox virus infection) is endemic in the Democratic Republic of the Congo (DRC) and manifests with hundreds to thousands of total body lesions and an estimated case fatality ratio of 11% (17% in children). In October 2022\, the PALM007 randomized placebo-controlled clinical trial of the safety and efficacy of tecovirimat for mpox was launched at remote sites in the DRC. Time to lesion resolution is the primary study endpoint\, making frequent lesion count assessments a critical study measure. Given the typically very high burden of skin lesions\, daily counting poses considerable human resource challenges to clinicians and clinical research staff. \nWe have established smartphone-based protocols for standardized total body photography to document mpox lesion appearance\, evolution\, and resolution. We will share our experience setting up\, standardizing\, and overseeing photodocumentation of mpox in remote trial sites\, discussing technical\, educational\, and cultural considerations. This rich standardized dataset of clade I mpox images will enable the development of artificial intelligence (AI) tools aimed to automate mpox lesion counting in future studies. Further\, new optical technologies may be advanced in response to this clinical need. Smartphone-based photodocumentation coupled with AI image analysis has become a benchmark for evaluating the performance of novel optical technologies. The PALM007 trial is supported by the Institut National de la Recherche Biomédicale (INRB) of the DRC and the National Institute of Allergy and Infectious Diseases (NIAID) of the US\, and funded by NCI Contract No.75N910D00024\, Task Order No.75N91020F00025. \nBiography \nDr. Inga Saknite is a Leading Researcher at the Biophotonics Laboratory\, the University of Latvia\, and an Adjoint Assistant Professor in Dermatology at the Vanderbilt University Medical Center in Nashville\, Tennessee\, the United States. Her main research interest is advancing noninvasive imaging technologies to quantitatively assess skin for clinical impact. Among other projects\, Dr. Saknite is currently leading photodocumentation of patients with mpox as part of a randomized controlled trial in the Democratic Republic of the Congo. She has multiple years of research experience in photographic\, hyperspectral\, and microscopic imaging of human skin\, standardized protocol and guideline development\, image processing and analysis\, and device and algorithm development. \nDr. Saknite received her PhD in physics from the University of Latvia in 2016. She was then awarded the Fulbright Scholarship to advance her translational research career at the Beckman Laser Institute of the University of California\, Irvine. From 2017 until 2021\, Dr. Saknite was a Postdoctoral Research Fellow at the Vanderbilt Dermatology Translational Research Clinic (VDTRC.org)\, and was named the inaugural Vanderbilt Postdoctoral Mentor of the Year in 2021. She has received several additional awards\, including the Abstract Achievement Award at the Annual Meeting of the American Society of Hematology and the best talk award at the Annual Vanderbilt Postdoctoral Association Symposium. \n  \nREGISTER HERE FOR ZOOM \n  \nClick here to register for in-person attendance (lunch will be served) \n 
URL:https://bli.uci.edu/event/inga-saknite-2/
LOCATION:BLI Library
CATEGORIES:2024 Hybrid Seminar Series,LAMP Seminar
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2025/03/Screenshot-2025-03-25-143017.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240201T120000
DTEND;TZID=America/Los_Angeles:20240201T130000
DTSTAMP:20260428T215809
CREATED:20250325T210232Z
LAST-MODIFIED:20250325T214945Z
UID:32945-1706788800-1706792400@bli.uci.edu
SUMMARY:Keiichiro Kagawa\, Ph.D. Eng.
DESCRIPTION:Enhancing SFDI’s functionality and performance with state-of-the-art CMOS image sensors\nAbstract  \nRecently\, new CMOS image sensors with high performance and functionalities such as near-infrared-enhanced global shutter\, multi-tap pixels for time-division-multiplexing (TDM) or time-resolved (TR) imaging\, and multi-aperture (MA) are emerging. At Shizuoka University\, TDM\, TR\, and MA CMOS image sensors are being developed for LiDAR and biomedical imaging applications. In my talk\, examples of SFDI systems with enhanced functionality and performance are shown. (1) multi-wavelength SFDI with suppression of ambient light bias and motion artifacts\, (2) fusion of SFDI and near-infrared spectroscopy (NIRS) using scanned multiple lines\, (3) fusion of SFDI and time-resolved imaging. \nBiography \nKeiichiro Kagawa received the Ph.D. degree in engineering from Osaka University\, Osaka\, Japan\, in 2001. In 2001\, he joined Graduate School of Materials Science\, Nara Institute of\nScience and Technology as an Assistant Professor. In 2007\, he joined Graduate School of Information Science\, Osaka University as an Associate Professor. In 2011\, he joined Shizuoka University as an Associate Professor. Since 2020\, he has been a Professor with Shizuoka University\, Hamamatsu\, Japan. His research interests cover high-performance computational CMOS image sensors\, imaging systems\, and biomedical applications. \n  \nREGISTER HERE FOR ZOOM \n  \nClick here to register for in-person attendance (lunch will be served) \n 
URL:https://bli.uci.edu/event/keiichiro-kagawa/
LOCATION:BLI Library
CATEGORIES:2024 Hybrid Seminar Series,LAMP Seminar
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2025/03/Screenshot-2025-03-25-140153.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20231130T120000
DTEND;TZID=America/Los_Angeles:20231130T130000
DTSTAMP:20260428T215809
CREATED:20250325T211458Z
LAST-MODIFIED:20250325T211547Z
UID:32953-1701345600-1701349200@bli.uci.edu
SUMMARY:Hanna Kim
DESCRIPTION:TIPS & TRICKS TO SUCCESSFUL IRB CLINICAL RESEARCH PROTOCOLS
URL:https://bli.uci.edu/event/hanna_kim/
LOCATION:BLI Library
CATEGORIES:Training Class
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2018/11/Hanna-Kim.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20231121T120000
DTEND;TZID=America/Los_Angeles:20231121T130000
DTSTAMP:20260428T215809
CREATED:20250325T212039Z
LAST-MODIFIED:20250325T212039Z
UID:32952-1700568000-1700571600@bli.uci.edu
SUMMARY:Xunbin Wei\, Ph.D.
DESCRIPTION:Light Treatment of Alzheimer’s Disease\nAbstract  \nPhotobiomodulation\, by utilizing low-power light in the visible or near-infrared spectrum to trigger biological responses in cells and tissues\, has been considered as a possible therapeutic strategy for Alzheimer’s disease (AD)\, while its specific mechanisms have remained elusive. Here\, we provide evidence that cognitive and memory impairment in an AD mouse model can be ameliorated by 1070-nm light via reducing cerebral β-amyloid (Aβ) burden\, the hallmark of AD. The glial cells\, including microglia and astrocytes\, play important roles in Aβ clearance. Our results show that 1070-nm light pulsed at 10 Hz triggers microglia rather than astrocyte responses in AD mice. The 1070-nm light-induced microglia responses with alteration in morphology and increased colocalization with Aβ are sufficient to reduce Aβ load in AD mice. \nMoreover\, we demonstrate that 1070-nm light pulsed at 10 Hz can reduce perivascular microglia and promote angiogenesis to further improve Aβ clearance. Our study confirms the important roles of microglia and cerebral vessels in the use of 1070-nm light for the treatment of AD mice and provides a framework for developing a novel therapeutic\napproach for AD. \nBiography \nDr. Wei received his bachelor in physics from University of Science and Technology of China\, Hefei. He received his PhD from Department of Physiology and Biophysics\, University of California\, Irvine. Dr. Wei completed his post-doc training at Children’s Hospital\, Harvard Medical School. From 2006-2010\, he was a professor in Fudan University\, China. From 2006-2010\, he was a professor and chair in Department of Biomedical Instrumentation\, School of Biomedical Engineering\, Shanghai Jiao Tong University\, China. \nCurrently\, he is a professor at Department of Biomedical Engineering\, Peking University. Dr. Wei is an SPIE Fellow\, and recipient of Chinese Outstanding Young Scholar Award. He has published more than 120 peer-reviewed papers\, including in Nature and PNAS. His research interests include cancer detection by optical means\, optical manipulation of cells\, and light treatment of Alzheimer disease. \n  \nREGISTER HERE FOR ZOOM \n  \nClick here to register for in-person attendance (lunch will be served) \n 
URL:https://bli.uci.edu/event/xunbin-wei/
LOCATION:BLI Library
CATEGORIES:2023 Virtual Seminar Series,LAMP Seminar
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2025/03/Screenshot-2025-03-25-141956.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230808T150000
DTEND;TZID=UTC:20230808T160000
DTSTAMP:20260428T215809
CREATED:20250325T205417Z
LAST-MODIFIED:20250325T205542Z
UID:32940-1691506800-1691510400@bli.uci.edu
SUMMARY:Woonggyu Jung\, Ph.D.
DESCRIPTION:Staining-free optical imaging techniques toward digital histopathology \nAbstract \nThe histological optical imaging is a gold standard method to observe the biological tissues\, which follows routine process such as dissection\, embedding\, sectioning\, staining\, visualization and interpretation of specimens. This technique has a long history of development\, and is used ubiquitously in pathology\, despite being highly time and labour-intensive. Advanced optical imaging techniques developed over the last decade have enabled to provide high sensitivity\, high resolution and non-invasive biological information. In particular\, new optical imaging contrast rather than chemical staining has been presented to be utilized in histopathology while showing the strong potential. However\, acquiring high throughput\, large volume tissue anatomy remains a difficult challenge due to the effect of light scattering\, which limits the penetration imaging depth and lateral resolution. Recently\, various optical imaging methods have been introduced to\ncreate volumetric anatomy data of ex vivo tissues using physical tissue sectioning or optical clearing. \nHere\, we introduce novel staining-free and multi-scale imaging modality based on scattering and phase contrast. Optical staining in histopathology could be key technique to build fast feedback of anatomy of tissues or organs due to its simplicity\, efficiency\, robustness\, and high-throughput capabilities. This presentation covers the latest work of large-scale and fast tissue imaging using optical coherence microscopy\, quantitative phase imaging and projection tomography. Specifically\, the talk will highlight comparison study over the conventional method in histopathology and its adaptation with artificial intelligence such as the virtual staining and resolution enhancement. \nBiography \nWoonggyu Jung received his Ph. D. in 2008 from the Department of Biomedical Engineering at the University of California\, Irvine. From 2001 to 2008\, he worked at the Beckman Laser Institute and Medical Clinic at UC Irvine. He also worked at the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign since January 2009. He has joined the faculty of UNIST in 2012\, and currently works as an associate professor of Department of Biomedical Engineering. He is also co-founder and CTO of start-up company\, Conecson which is focused on the futuristic business regarding to mobile-based medical devices. Dr. Jung has a strong research background in optical imaging technologies including optical coherence tomography (OCT)\, quantitative phase microscope (QPM)\, and miniaturized optical imaging probes. His research interest is to develop new optical technologies that address challenges in clinical medicine\, basic biological research and neuroscience. In previous work\, he developed a successful optical platform for in vivo translational research\, and has published more than 60 peer-reviewed journal papers in the field of biophotoics. \nFor more information or to schedule a meeting with the speaker\, please contact Xandra Dvornikova. \nSponsored by the Berns Family Laser and Microbeam Program \nHosted by: Dr. Zhongping Chen
URL:https://bli.uci.edu/event/woonggyu-jung-2/
LOCATION:BLI Library
CATEGORIES:2023 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2020/02/Woonggyu-Jung.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230709T080000
DTEND;TZID=America/Los_Angeles:20230720T170000
DTSTAMP:20260428T215809
CREATED:20230602T163824Z
LAST-MODIFIED:20230602T164418Z
UID:31417-1688889600-1689872400@bli.uci.edu
SUMMARY:2023 SHORT COURSE IN MULTISCALE BIOPHOTONICS
DESCRIPTION:2023 SHORT COURSE\nIN MULTISCALE BIOPHOTONICS\n(SCMB2023) \nJuly 9 – July 20\, 2023 \n  \nOpen to grad students\, university postdocs\, faculty and industry researchers \nAREAS COVERED:\nBiological Microscopy\nOptical Dosimetry\nOptical Property Determination\nWide-Field Spectroscopy and Imaging\nPhysiological Monitoring \nWORK WITH RECOGNIZED EXPERT COURSE LECTURERS\nHANDS-ON LABORATORY EXPERIENCE\nCAREER DEVELOPMENT PANELS\nTEAM SCIENCE TRAINING\nPROBLEM BASED LEARNING AND SO MUCH MORE! \nProgram Fees\nAcademics: $1000\nIndustrial Applicants: Contact Program Directors \n 
URL:https://bli.uci.edu/event/2023-short-course/
LOCATION:BLI Library
CATEGORIES:SHORT COURSE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230626T080000
DTEND;TZID=America/Los_Angeles:20230818T170000
DTSTAMP:20260428T215809
CREATED:20230602T200239Z
LAST-MODIFIED:20230602T200239Z
UID:31434-1687766400-1692378000@bli.uci.edu
SUMMARY:Access to Careers in Engineering and Sciences (ACES) HBCU Undergraduate Summer Training Program
DESCRIPTION:Access to Careers in Engineering and Sciences (ACES) HBCU Undergraduate Summer Training Program \nJune 26 – August 18\, 2023 \n  \nEvery summer\, 10 talented undergraduate students from historically black colleges and universities (HBCUs) are selected to travel across the country to attend Access to Careers in Engineering and Sciences (ACES)\, an eight-week summer training program at UCI Beckman Laser Institute & Medical Clinic. ACES introduces high-achieving\, underrepresented students to the breadth of UCI graduate programs in the fields of biomedical engineering\, biophotonics and related science\, technology\, engineering and math disciplines. \nACES students: \n\nwork alongside faculty mentors who are leaders in their field\nconduct leading-edge research in Institute facilities and labs\nlearn about careers in academia and industry\nattend workshops on taking the GRE\, writing a personal statement and preparing for graduate school\nmake connections valuable to gaining admission to graduate school\n\nClick here to learn more about ACES.
URL:https://bli.uci.edu/event/access-to-careers-in-engineering-and-sciences-aces-hbcu-undergraduate-summer-training-program/
LOCATION:BLI\, 1002 Health Sciences Rd\, Irvine\, CA\, 92612\, United States
CATEGORIES:ACES
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230615T120000
DTEND;TZID=America/Los_Angeles:20230615T130000
DTSTAMP:20260428T215809
CREATED:20250325T204318Z
LAST-MODIFIED:20250325T204318Z
UID:32933-1686830400-1686834000@bli.uci.edu
SUMMARY:Hyunmo Yang\, Ph.D.
DESCRIPTION:Deep Learning Applications in Biomedical Imaging\nAbstract  \nRecently developed deep learning techniques revolutionized image analysis methods in the last decade. Classification\, segmentation\, quantitative prediction\, and generating new data can be performed by the training of deep learning models. These tasks can directly be applied to biomedical imaging and successful applications will provide strong advantages to researchers and physicians in terms of efficiency for their studies and improvement in diagnosis. \nIn this talk\, I will discuss my recent studies that using deep learning techniques to the following topics: glaucoma screening from fundus photographs based on regional retinal nerve fiber layer (RNFL) thickness estimation using deep learning\, label-free digital histopathology with QPI imaging based on virtual staining and image classification techniques\, and high-throughput phenotype screening platform using office scanner. For these studies\, we have employed the convolution neural network (CNN) network architectures and trained them to perform image-to-number regression\, image classification\, image segmentation\, and image-to-image generation. The details of each approach will be also discussed. \nBiography \nDr. Hyunmo Yang earned his Ph.D. in physics from Ulsan National Institute of Science of Technology (UNIST) in Korea. After his degree in 2019\, he joined as a postdoc researcher to the translational biophotonics laboratory in department of biomedical engineering at UNIST. He is currently working on developing machine learning and deep learning applications for biomedical imaging. His research interests are digital medicine\, digital screening and digital histopathology using A.I. technology. \n  \nREGISTER HERE FOR ZOOM \n  \nClick here to register for in-person attendance (lunch will be served) \n 
URL:https://bli.uci.edu/event/hyunmo-yang/
LOCATION:BLI Library
CATEGORIES:2023 Virtual Seminar Series,LAMP Seminar
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2025/03/Screenshot-2025-03-25-134139-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230427T120000
DTEND;TZID=America/Los_Angeles:20230427T130000
DTSTAMP:20260428T215809
CREATED:20250325T203342Z
LAST-MODIFIED:20250325T204503Z
UID:32928-1682596800-1682600400@bli.uci.edu
SUMMARY:Roukuya Mamuti\, Ph.D.
DESCRIPTION:Tunable infrared structured laser generation and opto-thermal trapping of micro/nano particles\nAbstract  \nThis talk covers the experimental research and theoretical investigation of mid-infrared tunable optical vortex sources with versatile orbital angular momentum (OAM) and opto-thermophoretic trapping of micro and nano particles with mid-infrared fiber lasers. As a typical structured light\, optical vortex with a helical wavefront exhibits interesting physical properties\, including an annular spatial intensity profile and an OAM of owing to an on-axial phase singularity. Such properties of the vortex beam have been widely utilized in diverse applications. In the talk\, Dr. Mamuti presents generation of optical vortices with versatile OAM states from a nanosecond optical parametric oscillator (OPO) by appropriately shortening or extending the cavity. The system with a compact cavity configuration enables the production of a millijoule-level signal (idler) output with l =1~3 (0~-2) simply by tuning the wavelength of signal output. The system was further developed to create coherently coupled OAM states\, i.e.\, flower-shaped signal and wheel-shaped idler outputs\, arising from the coherent superposition of opposite-signed OAM states. \nFurthermore\, Dr. Mamuti proposed a method for opto-thermophoretic trapping with a 2 μm Tm-doped fiber laser. The infrared continuous-wave laser beam is directly and strongly absorbed by water solution\, and some local temperature gradient is generated around the focus. The particles are migrated along the temperature gradient and form a hexagonal close-packed structure at a bottom-glass solution interface. She has investigated the dependence of the phenomenon on the material\, particle size\, and laser power. Since the water molecules have a significant absorption in the 3-μm wavelength band\, a midinfrared Er:ZBLAN tunable fiber laser is applied for opto-thermophoretic trapping of particles diffusing in water. Through the laser wavelength dependence and single particle tracking analysis\, they found that particles are rapidly collected at the laser focus which is much faster than near infrared lasers. The system with 2 μm and 3 μm direct optothermal trapping could be extended in various fields\, such as bio sensing\, detection\, and sorting. \nBiography \nDr. Roukuya Mamuti received her Master’s and Ph.D. degrees in Optical Engineering from laser laboratory\, Chiba University\, Japan. Her graduate research mainly focused on the generation of tunable infrared structured lasers. After graduation\, she worked as a postdoctoral researcher at Laser Lab (the same lab where she earned her degree). Dr. Mamuti received 2 million Japanese yen of research grant from Kambayashi foundation (private funding). Later\, she worked in the Laser Science Laboratory at Toyota Technological Institute\, to develop optical trapping of micro/nano particles. Now\, she is seeking a research position to pursue her profession in laser-related research fields. \n  \nREGISTER HERE FOR ZOOM \n  \nClick here to register for in-person attendance (lunch will be served) \n 
URL:https://bli.uci.edu/event/roukuya-mamuti/
LOCATION:BLI Library
CATEGORIES:2023 Virtual Seminar Series,LAMP Seminar
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2025/03/Screenshot-2025-03-25-133315.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230420T090000
DTEND;TZID=America/Los_Angeles:20230420T100000
DTSTAMP:20260428T215809
CREATED:20230413T235332Z
LAST-MODIFIED:20250325T201003Z
UID:31266-1681981200-1681984800@bli.uci.edu
SUMMARY:Martin Lavery\, Ph.D.
DESCRIPTION:Environmental and Fiber Sensing with Structured Light \nAbstract  \nStructured light is being widely used to revolutionize the technologies used in optical trapping\, microscopy\, astronomical metrology\, optical communication\, quantum information systems\, and many others. One defines an optical wavefront that has been spatially shaped in its phase\, polarisation or intensity as structured light. Prof. Lavery will present an introduction to the research field and an overview of their work in the Structured Photonics Research Group\, at the University of Glasgow\, in the creation\, detection\, and application of shaped optical beams for a range of sensing applications. He will discuss the development of technologies to generate and measure structured light\, including reconfigurable platforms based on silicon Photonic Integrated Circuits (PICs). \n Further\, he will present their recent advances in utilising structured light for sensing in complex optical environments such as underwater scattering\, atmospheric turbulence\, and multimode optical fibers. They have developed approaches that use spatial mode sensitive receivers to extract features buried in aberrated optical fields that can increase the accuracy of the measurement of particulates in submersed channels\, measure wind speed and temperature from the air\, and sense changes in the shape of optical fibers. These sensors could be used for environmental pollution sensing in water\, failure monitoring in mechanical systems\, and sub-km weather monitoring critical for developing accurate climate models. \nBiography \nProfessor Martin Lavery is a Full Professor in Optics and is the leader of the Structured Photonics Research Group at the James Watt School of Engineering at the University of Glasgow (UofG). Prof. Lavery has a portfolio\nof over $6 million in independent research funding as Principal Investigator (PI) and is leading the H2020 Future and Emerging Technologies (FET-Open) consortium project named SuperPixels\, each of which have an array of international partners from both industry and academia. He has held the prestigious Royal Academy of\nEngineering (RAEng) Research Fellowship from 2014-2019. Prof. Lavery’s H-index is 41 with over 60 publications in peer-reviewed journals and over 80 conference\nmanuscripts that have collectively attracted over 11\,000 citations (Google Scholar\, Dec 2022). He has been awarded the 2013 Scopus Young Scientist of the Year for Physical Sciences\, the 2018 Mobile World Scholar Gold Medal\, and the 2019 Royal Society of Edinburgh Sir Thomas Makdougall Brisbane Medal for accomplishments in\noptical communication and sensing. \nREGISTER HERE FOR ZOOM \n 
URL:https://bli.uci.edu/event/martin-lavery-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2023 Virtual Seminar Series
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2023/04/image.1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230330T090000
DTEND;TZID=America/Los_Angeles:20230330T100000
DTSTAMP:20260428T215809
CREATED:20230328T165357Z
LAST-MODIFIED:20230328T165742Z
UID:31224-1680166800-1680170400@bli.uci.edu
SUMMARY:Daniel Razansky\, Ph.D.
DESCRIPTION:Cardio-oncology; Advanced optoacoustic imaging methods for biomedical research and clinical diagnostics \nAbstract  \nOptoacoustic imaging has achieved remarkable progress over the last decade\, benefiting from coordinated developments in optical and ultrasound technology\, probe chemistry\, and imaging theory. The technique is increasingly attracting attention of the biomedical research community due to its excellent spatial and temporal resolution\, centimeter scale penetration into living tissues\, versatile endogenous and exogenous optical absorption contrast. State-of-the-art implementations of multispectral optoacoustic tomography are based on multi-wavelength excitation of tissues to visualize specific molecules within opaque tissues. As a result\, optoacoustics can noninvasively deliver structural\, functional\, metabolic\, and molecular information from living tissues. \nThe talk covers advances in optoacoustic microscopy and tomography instrumentation\, reconstruction algorithms for ultrafast imaging\, as well as synergistic combinations with fluorescence\, magnetic resonance and ultrasound methods. Efforts are underway to explore potential of the technique in studying multi-scale dynamics of the brain and heart\, monitoring of therapies\, targeted molecular imaging applications and clinical diagnostics of patients in a number of indications\, such as breast and skin lesions\, inflammatory diseases and cardiovascular diagnostics. \nBiography \nProfessor Daniel Razansky holds the Chair of Biomedical Imaging with double appointments at the Faculty of Medicine\, University of Zurich and Department of Information Technologies and Electrical Engineering\, ETH Zurich in Switzerland\, where he also serves as Director of the joint Preclinical Imaging Center. \nHe earned degrees in Biomedical and Electrical Engineering from the Technion – Israel Institute of Technology and conducted postdoctoral research at the Harvard Medical School. Previously\, he was Professor of Molecular Imaging Engineering at the Technical University of Munich and Helmholtz Center Munich in Germany. \nThe Razansky Lab pioneered a number of bio-imaging technologies that were successfully commercialized and put into use in research labs and clinical facilities across the globe\, among them the multi-spectral optoacoustic tomography (MSOT) and hybrid optoacoustic ultrasound (OPUS). His research has been recognized by the German Innovation Prize and multiple awards from the ERC\, NIH\, SNF\, DFG and HFSP. He is also Fellow of the IEEE\, SPIE and Optica Societies. \nREGISTER HERE FOR ZOOM \n 
URL:https://bli.uci.edu/event/daniel-razansky-phd/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2023 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/03/updated.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230316T120000
DTEND;TZID=America/Los_Angeles:20230316T130000
DTSTAMP:20260428T215809
CREATED:20230314T184923Z
LAST-MODIFIED:20230314T184923Z
UID:31214-1678968000-1678971600@bli.uci.edu
SUMMARY:Mehmet Cilingiroglu\, MD\, FSCAI\, FACC\, FESC
DESCRIPTION:Cardio-oncology; Cardiovascular diseases in cancer patients \nAbstract  \nWith more advances in cancer therapy\, more patients are alive as cancer survivors than a decade ago.\nHowever\, cardiovascular disease is the number one reason for mortality in these cancer free patients.\nBeside the conventional risk factors for cardiovascular diseases\, radiation and chemotherapy and\ncancer specific immunotherapy contributes to increased risk. We will discuss the details of\ncardiovascular disease etiologies and treatment options in this specific patient population. \nBiography \nDr. Cilingiroglu is a well-established interventional cardiologist and structural heart interventionalist.\nHe has academic affiliations with several different universities in the USA as well as in EU for various\nresearch and educational collaborations. Beside providing excellent clinical cardiovascular care\, over\nthe last two decades he has been involved and lead many different investigator initiated and novel\ndevice development studies. Have been collaborating with Professor Milner and his team for many\nyears. \nREGISTER HERE FOR ZOOM \n 
URL:https://bli.uci.edu/event/mehmet-cilingiroglu/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/03/Mehmet.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230207T120000
DTEND;TZID=America/Los_Angeles:20230207T130000
DTSTAMP:20260428T215809
CREATED:20230314T184214Z
LAST-MODIFIED:20230314T184214Z
UID:31208-1675771200-1675774800@bli.uci.edu
SUMMARY:Jiawen Li\, Ph.D.
DESCRIPTION:Ultrathin 3D-printed Imaging Devices \nAbstract \nPreclinical studies and clinical diagnostics increasingly rely on optical techniques to visualize internal\norgans. Miniaturised catheters or endoscopes are necessary for imaging small and/or delicate\narteries. However\, current lens fabrication methods limit the performance of these ultrathin devices\,\nresulting in a poor combination of resolution\, depth of focus and multimodal imaging capability.\nThis talk will introduce her latest research to address these combined challenges. In particular\, she\nhas utilized 3D micro-printing technology to fabricate lenses\, with a diameter of less than 350 μm\,\ndirectly onto an optical fiber to achieve freeform designs for 1) aberration-corrected optical coherence\ntomography (OCT)\, 2) Bessel beam OCT\, and 3) highly-sensitive multimodal fluorescence+OCT\nimaging in vivo. \nBiography \nDr. Jiawen Li is a Fellow of L’Oréal-UNESCO\, National Heart Foundation and NHMRC\, and a Senior\nLecturer at the School of Electrical and Electronic Engineering\, the University of Adelaide. She received\nher Bachelor’s degree in Optical Engineering from Zhejiang University (China) in 2010\, and her PhD\ndegree in Biomedical Engineering from the University of California\, Irvine (USA) in 2015.\nSince finishing her PhD\, Dr. Li has secured >$2 million research funding as the lead chief/principal\ninvestigator and won numerous prestigious awards/honours (including national Superstar of STEM\,\nAustralian and New Zealand Optical Society Geoff Opat Early Career Researcher Prize\, Heart\nFoundation Paul Korner Innovation Award\, Young Tall Poppy Science Award\, etc.). Dr Li’s research\nfocuses on multimodal imaging\, ultrathin endoscopes\, optical sensing\, 3D micro-printing\, and optical\ncoherence tomography. \n\n 
URL:https://bli.uci.edu/event/jiawen-li-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/03/Jiawen2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230126T120000
DTEND;TZID=America/Los_Angeles:20230126T130000
DTSTAMP:20260428T215809
CREATED:20230314T183414Z
LAST-MODIFIED:20230314T183414Z
UID:31203-1674734400-1674738000@bli.uci.edu
SUMMARY:Yun Jing\, PhD
DESCRIPTION:Numerical Modeling of Medical Ultrasound \nAbstract  \nIn the last two decades\, we have witnessed substantial development in high intensity focused ultrasound (HIFU) for treating a\nbroad spectrum of diseases and medical conditions. As a non invasive surgical modality that can reach deep tissue\, HIFU has\nthe potential to revolutionize therapy. Although there are many numerical models available\, none can currently achieve both\nefficient and sufficiently accurate simulations for acoustic wave propagation in large scale\, heterogeneous biological media.\nExisting numerical models face two enduring dilemmas: they are either very efficient but not accurate due to invalid\napproximations\, or they are very accurate but computationally time consuming and therefore impractical in many cases. I will\ndiscuss our effort throughout the past 10 years in developing new numerical models for HIFU\, that aims to establish a\nbalance between accuracy and computational efficiency. I will focus on both the theoretical development and the practical\napplications of the numerical algorithm. I will also introduce our NIH funded project that aims to develop an open source\ntoolbox for modeling medical ultrasound (https://m-sound.github.io/mSOUND/home). \nBiography \nYun Jing\, Ph.D. was a research fellow at Brigham and Women’s Hospital\, and an assistant professor and associate professor\nat North Carolina State University\, prior to joining the Graduate Program in Acoustics at Penn State University in 2020.\nDr. Jing has published over 85 peer reviewed scientific manuscripts. Dr. Jing is fellow of ASA\, a senior member of IEEE\,\nand an associate editor of the Journal of the Acoustical Society of America and Frontiers in Materials. He has received\nnumerous awards such as the 2018 R. Bruce Lindsay Award from the Acoustical Society of America\, the 2018 IEEE\nUltrasonics Early Career Investigator award\, 2018 MIT Technology Review Innovator under 35 China award\, and the\nIEEE UFFC Star Ambassador Lectureship Award. Dr. Jing earned his B.S. in acoustics from Nanjing University\, China\,\nM.S.\, and Ph.D. in architectural acoustics from Rensselaer Polytechnic Institute. \n 
URL:https://bli.uci.edu/event/yun-jing-phd/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/03/jing.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230112T120000
DTEND;TZID=America/Los_Angeles:20230112T130000
DTSTAMP:20260428T215809
CREATED:20230109T213645Z
LAST-MODIFIED:20230109T213950Z
UID:31131-1673524800-1673528400@bli.uci.edu
SUMMARY:Lilit Garibyan\, MD\, PhD\, FAAD
DESCRIPTION:A Leadership Toolbox for Operationalizing Innovation at Your Institution \nAbstract  \nIn today’s challenging healthcare environment\, the importance of innovation has never been greater. Every healthcare institution anduniversity strive to be innovative\, but successful innovative cultures and programs are difficult to create and sustain especially in the busy and fast-paced healthcare settings. Creating an innovative culture requires having a structured process and framework that educates\, trains and rewards individuals who engage in innovation. \nThe “Magic Wand Initiative” was created at Massachusetts General Hospital to empowers and engages healthcare professional in problembased innovation. It is designed to bring innovation directly to clinicians\, reduce the barriers to engagement and provide necessary resourcesm for clinicial and research faculty to work collaboratively to solve unmet needs and generate outcomes. Over the last several years I have lectured about this revolutionary and impactful national and international curriculum called the “Magic Wand Initiative and Virtual Magic Wand program” http://www.magicwandinitiative.org/ to teach leaders and clinicians how to leverage innovation for outcomes. In this talk we will aim to:\n• Describe the importance of innovation in healthcare\n• Identify common barriers to innovation\n• Develop strategies that individuals and institutions can use to implement innovation \n  \nBiography \nDr. Lilit Garibyan MD\, PhD is a physician-scientist at Wellman Center for Photomedicine\, board certified dermatologist and faculty member at Harvard Medical School Department of Dermatology. She is listed as an inventor on 15 pending and granted patents in fields of medical devices\, immunology\, dermatology\, cardiology\, and medical innovation. Her research focuses on innovative biomedical translational discoveries aimed at identifying unmet medical needs and working with multidisciplinary teams to develop novel treatments. She used this same approach to pioneer injectable cooling devices for aesthetic and medical application since 2012. Several of her inventions have been licensed and led to venture-backed startup companies. She is the co-founder of two startup biotech companies which have resulted from her research discoveries. She serves on several scientific advisory boards for startup companies. \nDr. Garibyan is the co-founder and the Director of the “Magic Wand Initiative” and the Virtual Magic Wand programs\, which teach the process of innovation. These internationally recognized programs empower\, engage\, and teach professionals on how to identify unmet needs and collaborate to identify and implement solutions to problems. \nAs a humanitarian\, Dr. Garibyan has pioneered and established sustainable\, medical laser clinics in Armenia for effective treatments of scars and vascular anomalies. Her team has taken several lasers to Armenia and has trained Armenian physicians on the use of laser technology to treat life altering skin diseases. Dr. Garibyan recently founded and serves as the President of a nonprofit organization called “Face of Angel” to continue the mission of this humanitarian work. \nDr. Garibyan received her B.S. summa cum laude from University of California Los Angeles\, her M.D. from Harvard Medical School and her\nPh.D. from Harvard University in Experimental Pathology/Immunology. \n  \nREGISTER HERE FOR ZOOM \n 
URL:https://bli.uci.edu/event/lilit-garibyan-md-phd-faad/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/01/Lilit-Garibyan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221027T120000
DTEND;TZID=America/Los_Angeles:20221027T130000
DTSTAMP:20260428T215809
CREATED:20230109T214453Z
LAST-MODIFIED:20230109T214453Z
UID:31140-1666872000-1666875600@bli.uci.edu
SUMMARY:Gultekin Gulsen\, Ph.D.
DESCRIPTION:True multi-modality optical molecular imaging – where both modalities interact and work in harmony. \nAbstract  \nThe main goal of the molecular imaging community has been achieving higher resolution and better quantitative accuracy.\nFor nearly two decades\, I have been spending effort for the same purpose\, mainly integrating optical imaging with anatomic\nimaging modalities such as MRI and X-ray CT. For example\, my team has developed a gantry-based combined X-ray CT and\nFluorescence Tomography system for small animal imaging. This system is unique in that both X-ray CT and optical imaging\nsystems are on the same gantry rotating around the animal and capable of revealing cross-sectional background optical\nabsorption map and anatomic images that can be used to obtain quantitatively correct fluorophore concentration maps.\nAnother hybrid system that is being developed in my lab is a combined MRI-Diffuse Optical Tomography scanner for small\nanimal imaging in both absorbance & fluorescence modes. \nIn all of these applications\, optical and anatomic imaging modalities worked in harmony but independent from each other.\nRecently\, we have focused on development of novel multimodality techniques\, in which optical and anatomic imaging\nmodalities work in harmony and interact with each other to provide images that cannot be obtained solely with one or the\nother. This talk will highlight two of these true-multimodality imaging techniques developed in our lab: Photo-magnetic\nImaging (PMI) and Temperature Modulated Fluorescence Tomography (TM-FT)\, where optical tomography is achieved at MRI\nand Focused Ultrasound resolution\, respectively while preserving its superior sensitivity. \n  \nBiography \nDr. Gulsen is an Associate Professor in the Departments of Radiological Sciences\, Biomedical Engineering\, Physics & Astronomy\, and Electrical Engineering & Computer Science at the University of California\, Irvine. He has been serving as the Director of In vivo Functional Onco-Imaging Shared Resource of the UCI Cancer Center for more than15 years. His research involves development of both cutting-edge instrumentation and novel mathematical algorithms for multi-modality imaging techniques. Although most of those techniques have been related to optical molecular tomography\, his team was also involved in development of the the world’s first MR compatible SPECT small animal imaging and Positron Emission\nMammography systems. \n  \n 
URL:https://bli.uci.edu/event/gultekin-gulsen-phd/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/01/Gultekin-UCI-best-pic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220929T120000
DTEND;TZID=America/Los_Angeles:20220929T130000
DTSTAMP:20260428T215809
CREATED:20220624T202639Z
LAST-MODIFIED:20220719T172026Z
UID:30667-1664452800-1664456400@bli.uci.edu
SUMMARY:Errol Arkilic\, Ph. D.
DESCRIPTION:Commercialization and searching for a business model: why is spinning technology out of a lab so challenging? \nAbstract \nIn this talk\, we will explore the four critical challenges of getting technology out of a lab. Dr. Arkilic\, Chief Innovation Officer of UCI has spent his entire career in supporting getting technology out of Academic labs. He has been founder StrataGent Life Sciences\, Inc.\, lead program manager for the NSF SBIR program\, founder of the NSF I-Corps program and founder of M34 Capital\, a venture capital firm in Silicon Valley. \n  \nBiography \nErrol Arkilic is Chief Innovation Officer and Executive Director of University of California\, Irvine Beall Applied Innovation. At UCI\, he leads campus‐wide commercialization activity\, helping researchers turn knowledge into products and services that impact society. Prior to his role at UCI\, he was founder and CEO of M34 Capital. M34 is a private investment company that focuses on seed and early‐stage projects being spun out of academic research labs. He currently sits on three boards: Growcentia\, Inc. NeuroTrainer\, Inc. and Ellis Day Skin Science\, Inc. Previously\, Errol was the founding and lead program director for the National Science Foundation Innovation Corps program (I‐Corps). He led the I‐Corps effort from its inception until July 2013. Prior to this\, he was the lead software and services Program Director for the NSF SBIR program. Before his government service\, Errol was founder and CEO of StrataGent Life Sciences (Acquired by Corium International: CORI) and Manager of Product Engineering at Redwood Microsystems. He has a Ph.D. in Aero/Astro Engineering from MIT. \n  \nREGISTER HERE FOR ZOOM \nREGISTER HERE FOR IN PERSON \n 
URL:https://bli.uci.edu/event/errol-arkilic-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/06/Errol-Arkilic_square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220818T120000
DTEND;TZID=America/Los_Angeles:20220818T130000
DTSTAMP:20260428T215809
CREATED:20220811T162605Z
LAST-MODIFIED:20220811T163904Z
UID:30894-1660824000-1660827600@bli.uci.edu
SUMMARY:Jason B. King\, Ph. D.
DESCRIPTION:  \nLaser Beam Shaping for Surgery and Microbiopsy \nAbstract \nLasers are increasingly being used for surgery in a wide range of medical specialties due to their advantages over alternative\nsurgical tools. Advantages include precise material removal\, limited bleeding\, and delivery through optical fibers enabling use\nin body cavities and for minimally invasive surgeries. Advancements in laser technology including new laser wavelengths and\nhigher power continue to improve the performance and implementation of surgical lasers. Temporal beam shaping\, or pulse\nmodulation\, has been implemented into clinical laser systems to increase efficiency of urological surgeries\, leading to faster\,\nsafer procedures. However\, the precise mechanisms of temporally shaped laser ablation are not fully understood. The effects\nof spatial beam shaping on laser tissue ablation have not previously been explored.\nWe aim to understand the impact of temporal and spatial laser beam on laser ablation to improve the performance and\nincrease the applications of laser surgery. Working towards this aim\, a Ho:YAG laser was temporally and spatially altered and\nthe effects on tissue ablation were explored. We explored the mechanisms of pulse modulated ablation through experiments\non phantoms and native kidney stones. We discovered that increased ablation efficiency by pulse modulation is composition\ndependent. Next\, increased ablation efficiency by altering laser spatial shape was explored. We discovered that shaping the\nlaser beam into an annular shape led to an increase in ablation efficiency in both hard and soft tissues. Finally\, we explored\nthe application of spatially shaped laser ablation for laser microbiopsy to harvest sub-microliter (<1 mm3) tissue samples.\nLaser beam shaping\, pulse energy\, and application of cryogen spray cooling were optimized to successfully harvest tissue\nsections with observable histological features. Harvested tissues were imaged with confocal microscopy and “virtual H&E”\nmethods were used to digitally color the images to mimic H&E stained tissue sections. Laser microbiopsy with virtual H&E is\nminimally invasive\, precise\, and provides images in a fraction of the time of the traditional pathology workflow. \n  \nBiography \nDr. Jason King recently graduated with his PhD in biomedical engineering from the University of Texas at Austin. His work\nfocuses on optimization of laser ablation for surgery and biopsy through temporal and spatial laser beam shaping. This work\nincludes computational modeling and ablation experiments aimed at understanding light tissue interactions involved in laser\nablation. His other research interests include confocal microscopy and Raman spectroscopy for cancer diagnosis and\nmonitoring. \n  \nREGISTER HERE FOR ZOOM \nREGISTER HERE FOR IN PERSON \n 
URL:https://bli.uci.edu/event/jason-b-king-ph-d-2/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/08/Jasonbking.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220811T120000
DTEND;TZID=America/Los_Angeles:20220811T130000
DTSTAMP:20260428T215809
CREATED:20220811T163755Z
LAST-MODIFIED:20220811T163919Z
UID:30760-1660219200-1660222800@bli.uci.edu
SUMMARY:Olivia L. Lee\, MD
DESCRIPTION:  \nConfocal Microscopy for the Evaluation of OcularSurface Disease \nAbstract \nDiagnosis and treatment of ocular surface disease represents a large proportion of the average ophthalmologist’s\npractice. However\, this group of conditions is more heterogeneous and complex than the term “dry eye” conveys.\nFurther investigation of the pathophysiologic mechanisms underlying these conditions are underway\, and in vivo\nlaser scanning confocal microscopy (IVCM) has emerged as a suitable\, relatively novel\, minimally invasive tool for\nobtaining high-resolution images of tissues at the cellular level. Using this imaging device\, the in vivo visualization of\nthe human cornea can be employed to study ocular surface disease in a non-invasive manner. The use of IVCM\nprovides a new approach to evaluating the microscopic morphology of the cornea and our group has applied this to\nthe study of a variety of ocular surface diseases including Sjogrens syndrome\, Mucous Membrane Pemphigoid\, drug\ninduced dry eye\, Neurotrophic Keratitis\, Stevens Johnson Syndrome and more. IVCM is a promising technique for\nthe diagnosis\, prognostication\, staging and stratification of ocular surface disease. This talk will highlight the clinical\nand research applicability of this imaging technique as applied to ocular surface diseases. \n  \nBiography \nDr. Olivia L. Lee is a board-certified UCI Health ophthalmologist who specializes in corneal diseases and uveitis. Dr.\nLee received her medical degree from Baylor College of Medicine in Houston\, Texas\, followed by a residency in\nophthalmology from the New York Eye & Ear Infirmary in New York City\, where she also completed a fellowship in\nuveitis and ocular immunology. She completed a fellowship in cornea\, external disease and refractive surgery at the\nUCLA Stein Eye Institute. Before joining UCI Health\, she served as cornea fellowship director at the Doheny Eye\nCenter UCLA.\nDr. Lee’s research focuses on the use of anterior segment ophthalmic imaging to develop new clinical endpoints to\nobjectively characterize disease severity and guide clinical decision-making. Her clinical interests include\ninflammatory eye disease and complex anterior segment surgery. Dr. Lee has performed all types of corneal and\ncataract surgeries. \n  \nREGISTER HERE FOR ZOOM \nREGISTER HERE FOR IN PERSON \n 
URL:https://bli.uci.edu/event/olivia-l-lee-md/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/08/Olivia-Lee.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220726T130000
DTEND;TZID=America/Los_Angeles:20220726T140000
DTSTAMP:20260428T215809
CREATED:20220719T172002Z
LAST-MODIFIED:20220719T172002Z
UID:30717-1658840400-1658844000@bli.uci.edu
SUMMARY:Giulio Guagliumi\, M.D.
DESCRIPTION:Intervascular Imaging & Treatment Seminar \nAbout \nDr. Giulio Guagliumi was trained with Master in Interventional Cardiology at the Clinique Pasteur\, Toulouse\, France. He was awarded at Mayo Clinic and St. Mary Hospital\, Rochester in imaging and coronary physiology assessment of vascular response to intracoronary stents. He has a long-standing interventional practice with research expertise in acute myocardial infarction\, stent\, vascular biology\, intravascular imaging\, structural heart disease. Fellow of the Italian Society of Invasive Cardiology since 2003\, he was the Scientific Director of the GISE Congress in 2008-2009 and President of the Italian Society in 2009-2011. H’s fellow of the ESC\, member of EAPCI since 2004\, member of the scientific committee and executive board of EUROPCR; Co-chair EAPCI Program Scientific Committee for the ESC Congress 2012-2014: Expert Chair of the same Committee in 2015. Country champion of the European Stent for Life project in 2010-2014\, to correct inequalities in access to primary-PCI at Italian regional level. Promoter at the EAPCI level of the joint initiative with the largest Japanese society (CVIT). Professor emeritus 2013-2014 at the First Affiliated Hospital of Harbin Medical University. Since 2015\, Dr. Guagliumi was training the interventional cardiology unit personnel at the Second Affiliated Hospital of the Harbin Medical University in clinical use of the intracoronary imaging\, with focus on complex coronary artery disease. He worked as co-director with Prof. Yu and Prof. Jia in multiple national and international educational meetings held in Harbin\, including the most recent ASIA Pacific Hybrid Course on actionable imaging. He was appointed as Honorary Professor at the Harbin Medical University in 2019. \nDuring the COVID-19 disease period Dr. Guagliumi directed the Interventional Unit of PG23 Hospital\, working for all cardiovascular emergencies of the entire Bergamo Province. H’s the leading author of the COVID-19 pathology research publications that identified microthrombi as the major cause of myocardial damage. \nHe has ongoing scientific collaboration with major Universities and research centers including Beckmann Laser Unit\, University of California (Irvine)\, Case Western University (Cleveland\, Ohio)\, Emory University (Atlanta)\, MIT (Boston)\, CV Path Institute (Gaithersburg)\, Wakayama University (Japan)\, Harbin Medical University (China). Principal investigator and member of the Steering Committee in multiple prospective\, randomized\, international multicenter trials in primary-PCI\, coronary stenting\, DES\, intracoronary imaging (IVUS\, OCT). Author of 273 peer reviewed scientific manuscripts\, published across all prestigious cardiology journals\, including New England Journal\, Eur Heart Journal\, Lancet\, Circulation\, JACC\, JACC Imaging\, Eurointervention. He has more than 300 peer reviewed Abstracts presented at the main international scientific conferences. Reviewer of: Eur Heart Journal\, Circulation\, Circ Interv\, JACC\, JACC Interv\, JACC Imaging\, Nature Cardiovascular Medicine\, Eurointervention. Official grader of abstracts and clinical cases submitted to the main Congresses (EuroPCR\, ESC\, TCT\, TCT AP\, ENCORE etc). Dr. Guagliumi is the leading author of imaging chapters in multiple textbooks\, including the OCT chapter of the Interventional Cardiology Textbook- (Editor Topol-Teirstein) for the 6\, 7th\, 8th edition and now officially charged lead author for the new update #9 version. In 2014 he was listed by Thomson Reuters among the most influential researcher in the last ten years from inCites and the Web of Science. \n  \nBiography \nDr. Guagliumi research interest combines scientific and medical training\, expertise in conducting prospective\, randomized trials\, and leadership in the field of high-resolution imaging applied to evaluation of in-vivo stent vascular responses. Dr. Guagliumi a pioneer in clinical use of light-based imaging for evaluating coronary stenting in various prospective\, randomized\, controlled studies conducted in unstable coronary syndromes\, including ST elevation myocardial infarction\, and complex lesion settings (long lesions\, diabetes\, overlapping stents). His group has one of the largest existing experience in the world with Optical Coherence Tomography (OCT) to detect stent-tissue responses at different time points following implantation. His work is based on continuous confront and interaction with pathologists for validating OCT imaging signals  and interpretation and develop surrogate imaging variables predicting stent failure. With this as a foundation the Guagliumi laboratory set the way for conducting innovative in-vivo evaluation and optimization of most of the clinically approved bare metal and drug-eluting stents. H’s involved in early evaluation/discussion of light based technical and software innovations for the clinical use\, including OCT co-registration with coronary angiography\, novel artificial intelligence software implementation for automatic EEL detection and calcium quantification. His most recent publications have focused on how light-based intracoronary imaging helps to identify heterogeneous mechanisms of stent thrombosis and define surrogate imaging variables for anticipating the individual risk profile. Dr. Guagliumi is involved in innovative invasive and non invasive imaging and physiology research projects\, including the use of the light for plaque molding\, and innovative blood flow measurements with CTCA. \n  \nREGISTER HERE FOR ZOOM \nREGISTER HERE FOR IN PERSON \n 
URL:https://bli.uci.edu/event/giulio-guagliumi-m-d/
LOCATION:Zoom Event\, CA\, United States
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/07/profile_photo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220523T120000
DTEND;TZID=UTC:20220523T130000
DTSTAMP:20260428T215809
CREATED:20220515T163102Z
LAST-MODIFIED:20220515T163335Z
UID:30522-1653307200-1653310800@bli.uci.edu
SUMMARY:Michelle Digman\, Ph. D.
DESCRIPTION:FLIM and Mitometer enable metabolic profiling and tracking phenotypic changes in mitochondria in cancer cells \nAbstract \nThe hallmark of metabolic alteration of increase glycolysis\, i.e. Warburg effect\, in cancer cells together with atypical extracellular matrix structure may be responsible for tumor cell aggressiveness and drug resistance. While it is it known that tumor cells stiffen the ECM as the tumor progression occurs\, a direct relationship between ECM stiffness and altered metabolism has not been explicitly measured. Here we apply the phasor approach technique in fluorescence lifetime imaging microscopy (FLIM) to measure metabolic alteration as a function of ECM mechanics. We imaged and compared triple-negative breast cancer (TNBC) cells to non-cancerous cells on various ECM stiffness. Our results show that TNBC exhibit a decreased fraction of bound NADH\, (indicative of glycolysis\,) with increasing substrate stiffness. All other cell lines showed little to no change in fraction bound NADH on the varying collagen densities. Dysregulation of mitochondrial motion may contribute to the fueling of bioenergy demands in metastatic cancer. To measure mitochondria motion and analyze their fusion and fission events\, we developed a new algorithm called “mitometer” that is unbiased\, and allows for automated segmentation and tracking of mitochondria in live cell 2D and 3D time-lapse images. Together\, the automated segmentation and tracking algorithms and the innate user interface make Mitometer a broadly accessible tool.? \n  \nBiography \nDr. Digman was awarded a doctorate degree in Chemistry with specialization in Biochemistry from the University of Illinois at Chicago in 2003. She did her postdoctoral work in the Department of Physics at the University of Illinois at Urbana-Champaign in biophysics until this lab moved to the University of California Irvine. She became Optical Bio-Core Director until she joined the BME department in 2013. Her research lab is focused on developing novel biophysical and optical tools to study biological questions with the goal of applying the gained knowledge to the advancement of human medicine. Dr. Digman is AIMBE Fellow\, Scialog Fellow\, Allen Distinguished Investigator in Immunometabolism\, and has won several awards including the NSF-CAREER award\, the Hellman Fellowship\, the Fluorescence Young Investigator Award from the Biophysical Society\, the Faculty Innovation in Teaching award and has received the Henry Samueli Career Development Chair \n  \nREGISTER HERE
URL:https://bli.uci.edu/event/michelle-digman-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2022 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/05/Digman.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220411T120000
DTEND;TZID=UTC:20220411T130000
DTSTAMP:20260428T215809
CREATED:20220403T121058Z
LAST-MODIFIED:20220403T121821Z
UID:30476-1649678400-1649682000@bli.uci.edu
SUMMARY:Alvin Viray\, J.D.
DESCRIPTION:Technology Transfer and Entrepreneurship at UCI \nAbstract \nThis seminar will discuss “technology transfer”\, the process by which UCI (1) protects intellectual property (inventions and software) developed by its faculty\, staff\, researchers and grad students; and (2) commercializes this IP through licensing to an existing company or startup. Also discussed will be the services and resources at UCI’s Beall Applied Innovation for entrepreneurs willing to form a startup based upon the intellectual property they develop at UCI. If you are currently developing intellectual property (IP) at UCI\, would like to do so\, and/or are curious about entrepreneurship and startups\, this seminar will seek to answer any and all your questions: How to submit your invention/software to UCI’s technology transfer office (aka “Research Translation Group”); Who owns my intellectual property; How much do inventors get from UCI’s licensing deal; What is the services and resources are available to me as an entrepreneur doing a startup? \n  \nBiography \nAlvin Viray is the Associate Director of UC Irvine’s technology transfer office\, known as the Research Translation Group (RTG) at UCI’s Beall Applied Innovation. Alvin and his team receives and manages inventions developed by UCI’s faculty\, physicians\, and researchers. He reviews new invention disclosures for patentability and commercial viability. He negotiates and executes various intellectual property agreements on behalf of UCI\, including license agreements for startups and companies. A licensed patent attorney\, Alvin graduated from the University of San Diego School of Law before passing the California Bar and USPTO Patent Bar. Alvin received his bachelor’s from UCI where he frequently guest lectures on topics covering Patents\, Copyrights\, Trademarks\, Licensing\, and Startups. \n  \nREGISTER HERE
URL:https://bli.uci.edu/event/alvin-viray-j-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2022 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/04/Alvin-Viray.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220331T120000
DTEND;TZID=UTC:20220331T130000
DTSTAMP:20260428T215809
CREATED:20220321T225034Z
LAST-MODIFIED:20220403T121006Z
UID:30470-1648728000-1648731600@bli.uci.edu
SUMMARY:David A. Chalyan\, MD\, MSc
DESCRIPTION:Opportunities to Improve Clinical Outcomes with Intravascular Ultrasound (IVUS) in Lower Extremity Revascularizations \nAbstract \nPeripheral vascular disorders are prevalent and mounting health conditions\, particularly in light of the aging population. Both acute and chronic arterial and venous disease result in excess morbidity and mortality and dramatically reduce health-related quality of life. Yet\, despite the expanded indications in guidelines for the types and complexities of vascular lesions resulting in a rising volume of endovascular interventions in general\, we have not seen a meaningful impact on clinical outcomes like amputation rates\, which continue to increase despite better access to peripheral vascular procedures. With the known health outcome benefits of Intravascular Ultrasound (IVUS) in coronary applications and the much higher reintervention rates in peripheral vascular procedures\, the uptake of IVUS has been increasing in lower extremity revascularizations. In this seminar\, we examine the up-to-date evidence\, cross-disciplinary consensus and emerging Real-World Data (RWD) for the role of IVUS in peripheral interventions in order to provide guidance on where this invasive imaging modality may be most beneficial to improve the quality of patient care during lower extremity arterial and venous intervention. \n  \nBiography \nDavid A. Chalyan received his Doctor of Medicine degree from Roy J. and Lucille A. Carver College of Medicine at the University of Iowa and his Master of Science degree in Biomedical Engineering from the University of California\, Irvine where he studied invasive coronary hemodynamics\, angiography-based Fractional Flow Reserve\, and diastolic Fractional Flow Reserve. He currently holds a position in Philips Chief Medical Office \n  \nREGISTER HERE
URL:https://bli.uci.edu/event/david-a-chalyan-md-msc/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2022 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/03/Chalyan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220310T120000
DTEND;TZID=UTC:20220310T130000
DTSTAMP:20260428T215809
CREATED:20220301T192752Z
LAST-MODIFIED:20220301T192752Z
UID:30462-1646913600-1646917200@bli.uci.edu
SUMMARY:Dr. Maxim R. Shcherbakov\, Ph. D.
DESCRIPTION:Tunable photonic nanostructures for laser pulse control and dynamic imaging \nAbstract \nFor decades\, nanofabrication has been the driving force behind the transformations in electronics. Light-based devices currently experience a similar transition: nanostructure-based photonic elements bear promise to revolutionize several key technology areas\, such as telecommunications\, augmented reality\, remote sensing\, and imaging. In this talk\, I will introduce the concept of tunable photonic nanostructures\, where time can be leveraged as an additional degree of freedom to manipulate the flow of light on demand. In a multi-faceted study\, we will explore how silicon-based nanostructures can be used as ultrafast all-optical switches that can control light with light at subpicosecond timescales and record-low Joule-per-bit counts. Next\, by marrying designer nanostructures to a technologically mature switching agent\, liquid crystals\, we will demonstrate the world’s thinnest lens with an electrically tunable focal spot. We will conclude on remarks how our technology enables lightweight and compact imaging solutions for spatial light modulators\, mixed reality glasses\, head-on displays\, and microscopes\, and outline its potential biomedical applications. \n  \nBiography \nMaxim Shcherbakov is an assistant professor at UCI EECS. He was a postdoctoral associate with the School of Applied and Engineering Physics at Cornell University from 2016 to 2021. He received his M.S. and Ph.D. degrees in Physics from Lomonosov Moscow State University\, Russia. As a deputy group leader at Samsung Advanced Institute of Technology\, his research was focused on wearable electronics\, remote sensing\, and LiDARs. He is an author of more than 50 research papers and book chapters\, and recipient of awards in photonics\, telecommunications and nanotechnology. \n  \nREGISTER HERE
URL:https://bli.uci.edu/event/dr-maxim-r-shcherbakov-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2022 Virtual Seminar Series
ATTACH;FMTTYPE=image/png:https://bli.uci.edu/wp-content/uploads/2022/03/Maxim-R.-S.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220303T130000
DTEND;TZID=UTC:20220303T140000
DTSTAMP:20260428T215809
CREATED:20220216T231932Z
LAST-MODIFIED:20220222T233335Z
UID:30392-1646312400-1646316000@bli.uci.edu
SUMMARY:Dr. Lilangi Ediriwickrema\, M.D.
DESCRIPTION:Applications of Spatial Frequency Domain Imaging in Thyroid Eye Disease \nAbstract \nSpatial frequency domain imaging provides access to multi-spectral absorption and scattering information of biological chromophores and water to provide quantifiable detail about tissue hemodynamics and spectral content. We propose to use SFDI to define an optical signature map characteristic for healthy eyes\, and TED before\, during\, and after treatment. We will use this information to establish clinical end-points and understand strategies to modulate hemodynamics\, osmotic gradients\, and collagen remodeling. \n  \nBiography \nDr. Lilangi Ediriwickrema is a board-certified UCI Health ophthalmologist who specializes in ophthalmic plastic and reconstructive surgery\, neuro-ophthalmology and orbital disease. \nShe received her medical degree from the Yale School of Medicine in New Haven\, Conn. She completed an internship at Memorial Sloan Kettering Cancer Center in New York City and a residency in ophthalmology at the Keck School of Medicine of USC\, where she was chief resident. She also completed a fellowship in neuro-ophthalmology and orbital disease at Johns Hopkins University’s Wilmer Eye Institute in Baltimore\, Md.\, followed by fellowship training in ophthalmic plastic and reconstructive surgery at the Shiley Eye Institute at UC San Diego Health. \n  \nREGISTER HERE
URL:https://bli.uci.edu/event/dr-lilangi-ediriwickrema-m-d/
LOCATION:Zoom Event\, CA\, United States
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/02/Dr.-Lilangi-Ediriwickrema.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220224T120000
DTEND;TZID=UTC:20220224T130000
DTSTAMP:20260428T215809
CREATED:20220214T211746Z
LAST-MODIFIED:20220214T214408Z
UID:30368-1645704000-1645707600@bli.uci.edu
SUMMARY:Dr. Dmitri Lapotko\, Ph.D.\, D.Sc.
DESCRIPTION:Lasers in Nano-Surgery and Nano-Medicine: Plasmonic Nanobubbles \nAbstract\nTo improve the safety and efficacy of standards of care in diagnostics and treatment of clinically-challenging diseases including cancer\, we combine the laser and nanotechnology approaches into a precise on-demand mechanical impact an nano-scale\, a laser pulse-generated vapor nanobubble around plasmonic nanoparticles in target cells. This nano-event\, plasmonic nanobubble\, results from a novel physical-biological mechanism. Its mechanical impact was tuned to support cell level diagnostics\, drug release and intracellular injection of genetic or therapeutic payloads\, to enhance chemoradiation therapies in highly resistant and aggressive tumors\, to intraoperatively detect and destroy unresectable residual microtumors\, and to non-invasively detect bad actors\, all in personalized procedures with safe doses of nanoparticles and laser energies. Plasmonic nanobubble platform can be integrated with current or novel medical approaches to improve clinical outcomes where standards of care fail. \nBiography\nDmitri Lapotko obtained his MS in thermal physics and Ph.D. in laser applications from Belarus State University and Doctor of Science in bioengineering from Lyikov Heat and Mass Transfer Institute. His research in biophotonics and nanotechnology in basic\, applied and clinical science resulted in the invention of photothermal microscope for functional analysis of live cells\, laser-generated vapor nanobubbles (plasmonic nanobubbles) as a novel platform for diagnostic\, therapeutic and surgical technologies for cancer\, malaria and cardiovascular disease applications. \n  \nREGISTER HERE \n 
URL:https://bli.uci.edu/event/dr-dmitri-lapotko-ph-d-d-sc/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2022 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2022/02/Dmitri-Lapotko.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211216T120000
DTEND;TZID=UTC:20211216T130000
DTSTAMP:20260428T215809
CREATED:20211208T055702Z
LAST-MODIFIED:20211208T055807Z
UID:30087-1639656000-1639659600@bli.uci.edu
SUMMARY:Song Hu\, Ph. D.
DESCRIPTION:Light + Sound: Peering into Brain Function and Metabolism \nAbstract\nExploiting the optical absorption contrast of blood hemoglobin\, photoacoustic microscopy (PAM) is an emerging technology for label-free imaging of the microvasculature\, which plays an essential role in supplying oxygen to the biological tissue and maintaining the metabolic activity in vivo. The multi-parametric PAM developed in Dr. Hu’s lab enables\, for the first time\, comprehensive and quantitative characterization of the microvascular structure\, function\, and associated tissue oxygen metabolism at the microscopic level. In this seminar\, Dr. Hu will present their latest progress on the development of PAM and the integration of PAM with other intravital light microscopy techniques for studying brain function and energy metabolism. \nBiography\nDr. Hu received his B.S. and M.S. degrees in Electronic Engineering from Tsinghua University and Ph.D. degree in Biomedical Engineering from Washington University in St. Louis. His research focuses on the development of photoacoustic and optical technologies for high-resolution structural\, functional\, metabolic\, and molecular imaging in vivo. Dr. Hu has published over 70 peer-reviewed articles in journals including Science\, Nature\, Nature Neuroscience\, and Proceedings of the National Academy of Sciences\, and has delivered over 40 invited talks including a Neurotechnologies plenary talk at Photonics West (2018) and a President’s Symposium keynote talk at Annual Microcirculatory Society Meeting (2018). His publications\, including the 4th and 6th most cited articles in the Journal of Biomedical Optics since 2009 and the 5th most cited article in Optics Letters since 2007\, have accumulated around 9\,000 citations (h-index: 37). Dr. Hu is a recipient of the Ralph E. Powe Junior Faculty Enhancement Award (2014)\, the National Science Foundation Faculty Early Career Development (NSF CAREER) Award (2018)\, and the Chan Zuckerberg Initiative Frontiers of Imaging Award (2020). \nREGISTER HERE \nSponsored by the Michael and Roberta Berns Laser Microbeam Program
URL:https://bli.uci.edu/event/song-hu-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2021/12/Song-Hu.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211202T120000
DTEND;TZID=UTC:20211202T130000
DTSTAMP:20260428T215809
CREATED:20211130T053721Z
LAST-MODIFIED:20211130T053721Z
UID:30060-1638446400-1638450000@bli.uci.edu
SUMMARY:Wenbin Tan\, Ph. D.
DESCRIPTION:Vasculopathy in COVID-19 and Pathogenesis of Cutaneous Vascular Malformations \nAbstract\nSARS-CoV-2-associated vasculopathy under hyperlipidemia and pathological progression of congenital vascular\nabnormalities in Port Wine Stains. In the first part\, we will present our clinical data for the first discovery of dyslipidemia\nin COVID-19 patients which have been substantially recognized. Mechanistically\, we have shown evidence of niche why\nobese subjects are more vulnerable to SARS-CoV-2 attack. Using a spike protein–pseudotyped (Spp) lentivirus with the\nproper tropism of the SARS-CoV-2 spike protein on the surface\, we have found that Spp lentiviruses preferably attack to\nendothelial cells in heart in obese but not normal weight mice\, leading to exaggerated vasculopathy and cardiomyopathy.\nCells with over-expression of Spike protein have impaired lipid metabolic and autophagy formation pathways\, resulting in\nincreased cell death in response to lipotoxicity. In the second part\, we will discuss the clinical molecular pathology of\ninfantile and early childhood PWS to show that (1) PWS is a disease with pathological alterations involving the entire skin\nphysiological milieu; (2) pluripotent cells with the GNAQ (R183Q) may give rise to multilineages in PWS; and (3) exocytosis\nof extracellular vesicles is enhanced in PWS vasculatures. \nBiography\nDr. Tan received his medical degree and master degree in Molecular Biology from XiangYa School of Medicine\, China. He\nreceived his PhD in neurobiology and neurophysiology from University of California\, Los Angeles. He joined Beckman\nLaser Institute at UC Irvine as an assistant project scientist in 2010 under the mentorship of Dr. Stuart Nelson. In 2018\,\nhe joined the department of cell biology and anatomy at School of Medicine University of South Carolina as an associate\nprofessor. \nREGISTER HERE \nSponsored by the Michael and Roberta Berns Laser Microbeam Program
URL:https://bli.uci.edu/event/wenbin-tan-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2021/11/Wenbin-Tan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211014T120000
DTEND;TZID=UTC:20211014T130000
DTSTAMP:20260428T215809
CREATED:20211014T005755Z
LAST-MODIFIED:20211014T010429Z
UID:29834-1634212800-1634216400@bli.uci.edu
SUMMARY:Erin Buckley\, Ph. D.
DESCRIPTION:Illuminating Biomarkers of Stroke with Diffuse Optical Spectroscopies \nAbstract\nOur research group specializes in the development and application of diffuse optical spectroscopies to study the brain. These non-invasive\, light-based tools enable real-time bedside monitoring of microvascular hemodynamics. In this seminar\, I will focus on our recent work that uses these tools to identify biomarkers of stroke risk in two high-risk patient populations; subarachnoid hemorrhage and pediatric sickle cell disease. Moreover\, I will talk about how we have advanced the techniques to account for the confounding influences of hematocrit in the sickle cell cohort. \nBiography\nDr. Buckley is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. She is also an assistant professor at the Department of Pediatrics at Emory University. She received her PhD from the Department of Physics and Astronomy from the University of Pennsylvania in 2011 and completed postdoctoral training at the Children’s Hospital of Philadelphia and at Massachusetts General Hospital. Her research focuses on the development and validation of diffuse optical spectroscopies. \nREGISTER HERE \nSponsored by the Michael and Roberta Berns Laser Microbeam Program
URL:https://bli.uci.edu/event/erin-buckley-ph-d/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2021/10/Dr-Buckley-1.jpg
END:VEVENT
END:VCALENDAR